Cofilin, a hypoxia-regulated protein in murine lungs identified by 2DE: Role of the cytoskeletal protein cofilin in pulmonary hypertension

Proteomics

Volumn 13, Issue 1, 2013, Pages 75-88

  Veith, Christine ^a   Schmitt, Sigrid ^b   Veit, Florian ^a   Dahal, Bhola Kumar ^a   Wilhelm, Jochen ^a   Klepetko, Walter ^c   Marta, Gabriel ^c   Seeger, Werner ^a   Schermuly, Ralph Theo ^a   Grimminger, Friedrich ^a   Ghofrani, Hossein A ^a   Fink, Ludger ^a   Weissmann, Norbert ^a   Kwapiszewska, Grazyna ^a,d  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

2DE; Cell biology; Differential expression; Gene expression profiling; Hypertrophy; MALDI TOF MS

Indexed keywords

COFILIN; IMATINIB; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOLOGY; HYPOXIA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ACTIN DEPOLYMERIZING FACTORS; ANIMALS; ANOXIA; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; MICE; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS C-SIS; PULMONARY ARTERY; RATS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UP-REGULATION;

MURINAE; MUS; RATTUS;

EID: 84872377633     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200206     Document Type: Article

References (64)

1. Acker, H., Mechanisms and meaning of cellular oxygen sensing in the organism. Respir. Physiol. 1994, 95, 1-10.
2. Lopez-Barneo, J., Pardal, R., Ortega-Saenz, P., Cellular mechanism of oxygen sensing. Annu. Rev. Physiol. 2001, 63, 259-287.
3. Boutilier, R. G., St-Pierre, J., Surviving hypoxia without really dying. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2000, 126, 481-490.
4. Clerici, C., Matthay, M. A., Hypoxia regulates gene expression of alveolar epithelial transport proteins. J. Appl. Physiol. 2000, 88, 1890-1896.
5. Ghofrani, H. A., Voswinckel, R., Reichenberger, F., Weissmann, N. et al., Hypoxia- and non-hypoxia-related pulmonary hypertension-established and new therapies. Cardiovasc. Res. 2006, 72, 30-40.
6. Maggiorini, M., High altitude-induced pulmonary oedema. Cardiovasc. Res. 2006, 72, 41-50.
7. Hermann, J., Kovacs, G., Scheidl, S., Interdisciplinary point of contact between rheumatology and pneumology. Z. Rheumatol. 2008, 67, 407-410, 412-404.
8. Hu, C. J., Wang, L. Y., Chodosh, L. A., Keith, B., Simon, M. C., Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol. Cell Biol. 2003, 23, 9361-9374.
9. Fink, L., Kohlhoff, S., Stein, M. M., Hanze, J. et al., cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue. Am. J. Pathol. 2002, 160, 81-90.
10. Li, D., Teng, X., Johns, R. A., Up-regulation of angiogenic factor expression in hypoxia-treated mouse lung demonstrated by DNA array technique. Chest 2002, 121, 78S.
11. Laudi, S., Steudel, W., Jonscher, K., Schoning, W. et al., Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension. Proteomics 2007, 7, 2469-2478.
12. Kwapiszewska, G., Wygrecka, M., Marsh, L. M., Schmitt, S. et al., Fhl-1, a new key protein in pulmonary hypertension. Circulation 2008, 118, 1183-1194.
13. Kwapiszewska, G., Wilhelm, J., Wolff, S., Laumanns, I. et al., Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension. Respir. Res. 2005, 6, 109.
14. Schermuly, R. T., Dony, E., Ghofrani, H. A., Pullamsetti, S. et al., Reversal of experimental pulmonary hypertension by PDGF inhibition. J. Clin. Invest. 2005, 115, 2811-2821.
15. Dahal, B. K., Heuchel, R., Pullamsetti, S. S., Wilhelm, J. et al., Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-beta. Pulm. Circ. 2011, 1, 259-268.
16. O'Farrell, P. H., High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
17. Gorg, A., Drews, O., Luck, C., Weiland, F., Weiss, W., 2-DE with IPGs. Electrophoresis 2009, 30(Suppl 1), S122-S132.
18. Zörb, C., Schmitt, S., Neeb, A., Karl, S. et al., The biochemical reaction of maize (Zea mays L.) to salt stress is characterized by a mitigation of symptoms and not by a specific adaptation. Plant Sci. 2004, 167, 91-100.
19. Fijak, M., Iosub, R., Schneider, E., Linder, M. et al., Identification of immunodominant autoantigens in rat autoimmune orchitis. J. Pathol. 2005, 207, 127-138.
20. Hecker, M., Zaslona, Z., Kwapiszewska, G., Niess, G. et al., Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 2010, 182, 805-818.
21. Kwapiszewska, G., Markart, P., Dahal, B. K., Kojonazarov, B. et al., PAR-2 inhibition reverses experimental pulmonary hypertension. Circ. Res. 2012, 110, 1179-1191.
22. Waypa, G. B., Chandel, N. S., Schumacker, P. T., Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ. Res. 2001, 88, 1259-1266.
23. Parsons, J. T., Horwitz, A. R., Schwartz, M. A., Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat. Rev. Mol. Cell Biol. 2010, 11, 633-643.
24. Wary, K. K., Kohler, E. E., Chatterjee, I., Focal adhesion kinase regulation of neovascularization. Microvasc. Res. 2011, 83, 64-70.
25. Bornfeldt, K. E., Raines, E. W., Graves, L. M., Skinner, M. P. et al., Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann. NY Acad. Sci. 1995, 766, 416-430.
26. Ouiddir, A., Planes, C., Fernandes, I., VanHesse, A., Clerici, C., Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 1999, 21, 710-718.
27. Hardie, D. G., Hawley, S. A., AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 2001, 23, 1112-1119.
28. Hochachka, P. W., Buck, L. T., Doll, C. J., Land, S. C., Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc. Natl. Acad. Sci. USA 1996, 93, 9493-9498.
29. Tinton, S., Tran-Nguyen, Q. N., Buc-Calderon, P., Role of protein-phosphorylation events in the anoxia signal-transduction pathway leading to the inhibition of total protein synthesis in isolated hepatocytes. Eur. J. Biochem. 1997, 249, 121-126.
30. Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L. et al., Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005, 105, 659-669.
31. Semenza, G. L., Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, 2007, cm8.
32. Kelly, S. M., Pabit, S. A., Kitchen, C. M., Guo, P. et al., Recognition of polyadenosine RNA by zinc finger proteins. Proc. Natl. Acad. Sci. USA 2007, 104, 12306-12311.
33. Reed, V. S., Wastney, M. E., Yang, D. C., Mechanisms of the transfer of aminoacyl-tRNA from aminoacyl-tRNA synthetase to the elongation factor 1 alpha. J. Biol. Chem. 1994, 269, 32932-32936.
34. Bacher, G., Lutcke, H., Jungnickel, B., Rapoport, T. A., Dobberstein, B., Regulation by the ribosome of the GTPase of the signal-recognition particle during protein targeting. Nature 1996, 381, 248-251.
35. Ueyama, T., Kasahara, H., Ishiwata, T., Yamasaki, N., Izumo, S., Csm, a cardiac-specific isoform of the RNA helicase Mov10l1, is regulated by Nkx2.5 in embryonic heart. J. Biol. Chem. 2003, 278, 28750-28757.
36. Brazin, K. N., Mallis, R. J., Fulton, D. B., Andreotti, A. H., Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A. Proc. Natl. Acad. Sci. USA 2002, 99, 1899-1904.
37. Thatcher, T. H., Gorovsky, M. A., Phylogenetic analysis of the core histones H2A, H2B, H3, and H4. Nucleic Acids Res. 1994, 22, 174-179.
38. Busso, N., Karababa, M., Nobile, M., Rolaz, A. et al., Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PLoS One 2008, 3, e2267.
39. Yang, T., Chan, N. Y., Sauve, A. A., Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells. J. Med. Chem. 2007, 50, 6458-6461.
40. Badesch, D. B., Orton, E. C., Zapp, L. M., Westcott, J. Y. et al., Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 1989, 1, 489-498.
41. Carvalho-Oliveira, I. M., Charro, N., Aarbiou, J., Buijs-Offerman, R. M. et al., Proteomic analysis of naphthalene-induced airway epithelial injury and repair in a cystic fibrosis mouse model. J. Proteome Res. 2009, 8, 3606-3616.
42. Howell, K., Preston, R. J., McLoughlin, P., Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J. Physiol. 2003, 547, 133-145.
43. Dai, Y. P., Bongalon, S., Tian, H., Parks, S. D. et al., Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats. Vascul. Pharmacol. 2006, 44, 275-282.
44. Kim, H. R., Appel, S., Vetterkind, S., Gangopadhyay, S. S., Morgan, K. G., Smooth muscle signalling pathways in health and disease. J. Cell Mol. Med. 2008, 12, 2165-2180.
45. Farmer, D. G., Kennedy, S., RAGE, vascular tone and vascular disease. Pharmacol. Ther. 2009, 124, 185-194.
46. Spiekerkoetter, E., Guignabert, C., de Jesus Perez, V., Alastalo, T. P. et al., S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circ. Res. 2009, 105, 639-647, 613 p following 647.
47. Barman, S. A., Zhu, S., White, R. E., RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension. Vasc. Health Risk Manag. 2009, 5, 663-671.
48. Laumanns, I. P., Fink, L., Wilhelm, J., Wolff, J. C. et al., The noncanonical WNT pathway is operative in idiopathic pulmonary arterial hypertension. Am. J. Respir. Cell Mol. Biol. 2009, 40, 683-691.
49. Palmgren, S., Vartiainen, M., Lappalainen, P., Twinfilin, a molecular mailman for actin monomers. J. Cell Sci. 2002, 115, 881-886.
50. Jeffery, T. K., Wanstall, J. C., Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol. Ther. 2001, 92, 1-20.
51. Hotulainen, P., Paunola, E., Vartiainen, M. K., Lappalainen, P., Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells. Mol. Biol. Cell 2005, 16, 649-664.
52. Zebda, N., Bernard, O., Bailly, M., Welti, S. et al., Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J. Cell Biol. 2000, 151, 1119-1128.
53. Wang, W., Mouneimne, G., Sidani, M., Wyckoff, J. et al., The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J. Cell Biol. 2006, 173, 395-404.
54. Vogel, S., Wottawa, M., Farhat, K., Zieseniss, A. et al., Prolyl hydroxylase domain (PHD) 2 affects cell migration and F-actin formation via RhoA/rho-associated kinase-dependent cofilin phosphorylation. J. Biol. Chem. 2010, 285, 33756-33763.
55. Negash, S., Narasimhan, S. R., Zhou, W., Liu, J. et al., Role of cGMP-dependent protein kinase in regulation of pulmonary vascular smooth muscle cell adhesion and migration: effect of hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2009, 297, H304-H312.
56. Perros, F., Montani, D., Dorfmuller, P., Durand-Gasselin, I. et al., Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 2008, 178, 81-88.
57. Bongalon, S., Dai, Y. P., Singer, C. A., Yamboliev, I. A., PDGF and IL-1beta upregulate cofilin and LIMK2 in canine cultured pulmonary artery smooth muscle cells. J. Vasc. Res. 2004, 41, 412-421.
58. Song, X., Chen, X., Yamaguchi, H., Mouneimne, G. et al., Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells. J. Cell Sci. 2006, 119, 2871-2881.
59. Foletta, V. C., Lim, M. A., Soosairajah, J., Kelly, A. P. et al., Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J. Cell Biol. 2003, 162, 1089-1098.
60. Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N. et al., Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 1999, 285, 895-898.
61. Marcoux, N., Vuori, K., EGF receptor activity is essential for adhesion-induced stress fiber formation and cofilin phosphorylation. Cell Signal 2005, 17, 1449-1455.
62. Mouneimne, G., Soon, L., DesMarais, V., Sidani, M. et al., Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J. Cell Biol. 2004, 166, 697-708.
63. Lau, C., Lytle, C., Straus, D. S., DeFea, K. A., Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium. Am. J. Physiol. 2011, 300, C113-C123.
64. Zoudilova, M., Kumar, P., Ge, L., Wang, P. et al., Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J. Biol. Chem. 2007, 282, 20634-20646.